Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

357 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Safety and efficacy of osimertinib rechallenge or continuation after pneumonitis: A multicentre retrospective cohort study.
Imaji M, Fujimoto D, Sato Y, Sakata Y, Oya Y, Tamiya M, Suzuki H, Ikeda H, Kijima T, Matsumoto H, Kanazu M, Hino A, Inaba M, Tsukita Y, Arai D, Maruyama H, Hara S, Tsumura S, Kobe H, Sumikawa H, Sakata S, Yamamoto N. Imaji M, et al. Among authors: fujimoto d. Eur J Cancer. 2023 Jan;179:15-24. doi: 10.1016/j.ejca.2022.10.029. Epub 2022 Nov 12. Eur J Cancer. 2023. PMID: 36470023
Real-World Data Analysis of Pembrolizumab Monotherapy for NSCLC Using Japanese Postmarketing All-Case Surveillance Data.
Terai H, Soejima K, Shimokawa A, Horinouchi H, Shimizu J, Hase T, Kanemaru R, Watanabe K, Ninomiya K, Aragane N, Yanagitani N, Sakata Y, Seike M, Fujimoto D, Kasajima M, Kubo A, Kusumoto S, Oyamada Y, Fujiwara K, Mori M, Hashimoto M, Shingyoji M, Kodani M, Sakamoto J, Agatsuma T, Kashiwabara K, Inomata M, Tachihara M, Tanaka K, Hayashihara K, Koyama N, Matsui K, Minato K, Jingu D, Sakashita H, Hara S, Naito T, Okada A, Tanahashi M, Sato Y, Asano K, Takeda T, Nakazawa K, Harada T, Shibata K, Kato T, Miyaoka E, Yoshino I, Gemma A, Mitsudomi T. Terai H, et al. Among authors: fujimoto d. JTO Clin Res Rep. 2022 Sep 1;3(11):100404. doi: 10.1016/j.jtocrr.2022.100404. eCollection 2022 Nov. JTO Clin Res Rep. 2022. PMID: 36275911 Free PMC article.
A phase II study (WJOG12819L) to assess the efficacy of osimertinib in patients with EGFR mutation-positive NSCLC in whom systemic disease (T790M-negative) progressed after treatment with first- or second-generation EGFR TKIs and platinum-based chemotherapy.
Takeda M, Shimokawa M, Nakamura A, Nosaki K, Watanabe Y, Kato T, Hayakawa D, Tanaka H, Takahashi T, Oki M, Tachihara M, Fujimoto D, Hayashi H, Yamaguchi K, Yamamoto S, Iwama E, Azuma K, Hasegawa K, Yamamoto N, Nakagawa K. Takeda M, et al. Among authors: fujimoto d. Lung Cancer. 2023 Mar;177:44-50. doi: 10.1016/j.lungcan.2023.01.011. Epub 2023 Jan 28. Lung Cancer. 2023. PMID: 36731290 Free article. Clinical Trial.
Outcomes of Chemoimmunotherapy Among Patients With Extensive-Stage Small Cell Lung Cancer According to Potential Clinical Trial Eligibility.
Fujimoto D, Morimoto T, Tamiya M, Hata A, Matsumoto H, Nakamura A, Yokoyama T, Taniguchi Y, Uchida J, Sato Y, Yokoi T, Tanaka H, Furuya N, Masuda T, Sakata Y, Miyauchi E, Hara S, Saito G, Miura S, Kanazu M, Yamamoto N, Akamatsu H. Fujimoto D, et al. JAMA Netw Open. 2023 Feb 1;6(2):e230698. doi: 10.1001/jamanetworkopen.2023.0698. JAMA Netw Open. 2023. PMID: 36826813 Free PMC article.
Predictors of target lesion revascularisation after drug-eluting stent implantation for calcified nodules: an optical coherence tomography study.
Hamana T, Kawamori H, Toba T, Kakizaki S, Nakamura K, Fujimoto D, Sasaki S, Fujii H, Osumi Y, Fujioka T, Nishimori M, Kozuki A, Shite J, Iwasaki M, Takaya T, Hirata KI, Otake H. Hamana T, et al. Among authors: fujimoto d. EuroIntervention. 2023 Jun 5;19(2):e123-e133. doi: 10.4244/EIJ-D-22-00836. EuroIntervention. 2023. PMID: 36876497 Free article.
Real-world clinical outcomes of percutaneous transluminal septal myocardial ablation for patients with drug-refractory hypertrophic obstructive cardiomyopathy: results from a retrospective multicenter registry of non-high-volume centers.
Nakamura K, Toba T, Otake H, Kakizaki S, Fujimoto D, Takahashi Y, Fukuyama Y, Kawamori H, Tanaka H, Takaya T, Iwasaki M, Kozuki A, Kawai H, Hayashi T, Shite J, Hirata KI. Nakamura K, et al. Among authors: fujimoto d. Heart Vessels. 2022 Nov;37(11):1937-1946. doi: 10.1007/s00380-022-02100-4. Epub 2022 May 31. Heart Vessels. 2022. PMID: 35641828
Optical Coherence Tomography Fractional Flow Reserve and Cardiovascular Outcomes in Patients With Acute Coronary Syndrome.
Kakizaki S, Otake H, Seike F, Kawamori H, Toba T, Nakano S, Tanimura K, Takahashi Y, Fukuyama Y, Fujimoto D, Nakamura K, Fujii H, Kozuki A, Shite J, Iwasaki M, Takaya T, Yamaguchi O, Hirata KI. Kakizaki S, et al. Among authors: fujimoto d. JACC Cardiovasc Interv. 2022 Oct 24;15(20):2035-2048. doi: 10.1016/j.jcin.2022.08.010. Epub 2022 Sep 28. JACC Cardiovasc Interv. 2022. PMID: 36182656 Free article.
Prediction of the debulking effect of rotational atherectomy using optical frequency domain imaging: a prospective study.
Hamana T, Kawamori H, Toba T, Nishimori M, Tanimura K, Kakizaki S, Nakamura K, Fujimoto D, Sasaki S, Osumi Y, Fujii M, Iwane S, Yamamoto T, Naniwa S, Sakamoto Y, Fukuishi Y, Matsuhama K, Hirata KI, Otake H. Hamana T, et al. Among authors: fujimoto d. Cardiovasc Interv Ther. 2023 Jul;38(3):316-326. doi: 10.1007/s12928-023-00928-9. Epub 2023 Apr 5. Cardiovasc Interv Ther. 2023. PMID: 37020066 Free PMC article.
Cholesterol uptake capacity: A new measure of high-density lipoprotein functionality as a predictor of subsequent revascularization in patients undergoing percutaneous coronary intervention.
Fujimoto D, Otake H, Kawamori H, Toba T, Nagao M, Nakano S, Tanimura K, Takahashi Y, Fukuyama Y, Kakizaki S, Nakamura K, Harada A, Murakami K, Iino T, Toh R, Hirata KI. Fujimoto D, et al. Atherosclerosis. 2022 Mar;345:44-50. doi: 10.1016/j.atherosclerosis.2022.01.014. Epub 2022 Jan 24. Atherosclerosis. 2022. PMID: 35115159
357 results